Login

Introducing Berkshire Grey's Next-Gen Mobile Robots for Efficient Fulfillment | Tom Wagner - CEO of berkshire grey inc 00:10:00

Share On Facebook Share On Twitter

Tom Wagner is the CEO of berkshire grey inc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Schizophrenia Assessment: Monitoring Symptoms, Treatment, and Side Effects
00:10:00
Commonwealth Capital Seeking Experienced Managing Directors and Associates for Company Incubation
00:10:00
MIND C.T.I. Ltd's workplace culture, rated by employees on Comparably in October 2017, receives high scores.
00:10:00
From Paper Routes to Financial Stewardship: Tim Harrison's Journey
00:10:00
Severn Trent CEO Liv Garfield addressing investors at the Hardman & Co Investor Forum.
00:10:00
Platinum Group Metals: Capitalizing on Growing Palladium Demand with Major South African Deposit
00:10:00
Buddy CRM and VenuIQ's long association with Kellton | David McLauchlan, CEO, Buddy Platform Ltd BUD:ASX
00:10:00
empower consumers to live on their terms|David Wu,General Partner,Maveron
00:10:00
Weekly Market Report: March 12, 2018 | Thomas J. Saunders, Managing Director, Winthrop Partners.
00:10:00
I-Dracreto: Holcim's Revolutionary Concrete Technology Launch! | Santiago María Ojea Quintana - President of Holcim Argentina
00:10:00
Manufacturing Marvels: Acker Drill Company’s Legacy in Drilling Tools and Equipment
00:10:00
Navigating the Future of Energy: Rhett Bennett on Black Mountain's Expansion and the Critical Role of Nickel | Rhett Bennett, CEO, Black Mountain Energy Ltd.

© 2017 - Neuhu+